Characteristics of medication errors with parenteral cytotoxic drugs.

European Journal of Cancer Care
A Fyhr, R Akselsson

Abstract

Errors involving cytotoxic drugs have the potential of being fatal and should therefore be prevented. The objective of this article is to identify the characteristics of medication errors involving parenteral cytotoxic drugs in Sweden. A total of 60 cases reported to the national error reporting systems from 1996 to 2008 were reviewed. Classification was made to identify cytotoxic drugs involved, type of error, where the error occurred, error detection mechanism, and consequences for the patient. The most commonly involved cytotoxic drugs were fluorouracil, carboplatin, cytarabine and doxorubicin. The platinum-containing drugs often caused serious consequences for the patients. The most common error type were too high doses (45%) followed by wrong drug (30%). Twenty-five of the medication errors (42%) occurred when doctors were prescribing. All of the preparations were delivered to the patient causing temporary or life-threatening harm. Another 25 of the medication errors (42%) started with preparation at the pharmacies. The remaining 10 medication errors (16%) were due to errors during preparation by nurses (5/60) and administration by nurses to the wrong patient (5/60). It is of utmost importance to minimise the potential for...Continue Reading

References

Aug 5, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·B ZernikowU Bode
Oct 13, 2001·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·J PhillipsC Pamer
Apr 30, 2002·Medical and Pediatric Oncology·Bernhard ErdlenbruchLise M Bjerre
Nov 9, 2002·European Journal of Pediatrics·Bernhard FreyOskar Baenziger
Nov 28, 2002·The Annals of Pharmacotherapy·Timothy S Lesar
Oct 7, 2003·Journal of Pediatric Hematology/oncology·Robert I LiemRobert J Arceci
Apr 17, 2004·Pharmacy World & Science : PWS·Xavier PourratAnnick Rouleau
Oct 26, 2005·Cancer·Tejal K GandhiDavid W Bates
Feb 18, 2006·Clinical Journal of Oncology Nursing·Lisa Schulmeister
Oct 26, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robin E Ferner, Jeffrey K Aronson
Jun 3, 2008·Clinical Journal of Oncology Nursing·Lisa Schulmeister
Jul 22, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·A MalikV S Mehta
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathleen E WalshJerry H Gurwitz
Mar 24, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·E Vila-TorresN V Jiménez-Torres
Jun 19, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Brian C O'NealRick J Couldry
Feb 2, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Laurel Kovacic, Carole Chambers

❮ Previous
Next ❯

Citations

Apr 18, 2015·Pharmacotherapy·Claudia LangebrakeCarina Hohmann
Oct 21, 2014·Journal of Clinical Pharmacy and Therapeutics·L SarfatiC Rioufol
May 17, 2017·Journal of Forensic Sciences·Petr HandlosMarek Joukal
Jun 7, 2018·European Journal of Cancer Care·Thamer Ali Al Khawaldeh, Mayyada Wazaify
Aug 23, 2019·European Journal of Cancer Care·Valentina LichtnerJohanna I Westbrook
Oct 24, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Natalia C DuartePatricia Moriel
May 14, 2020·Acta Oncologica·AnnSofie FyhrÅsa Ek
Mar 20, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Chloé HerledanCatherine Rioufol
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Aline SaadMarcel Massoud

❮ Previous
Next ❯

Software Mentioned

Maria
Oncolex

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.